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Summary An experimental trial in the induction of canine gastric cancers was conducted to study the
relationship between the histological differentiation of adenocarcinoma and the duration of administration of
the carcinogen, N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG). Twenty-three adult Beagle dogs were divided
into three groups according to the duration of administration. Over 3 months administration, the total dose
of ENNG per animal was 5.85 g, and only signet ring cell carcinomas and poorly differentiated adeno-
carcinomas were induced in the antral mucosa of the stomach in 5 of 10 recipients. During 6 and 9 months
administration, the total doses per animal were 11.70g and 17.55g, well differentiated adenocarcinomas were
observed in 12 of 13 animals and they coexisted with poorly differentiated adenocarcinomas and/or signet
ring cell carcinomas. Atrophic hyperplastic gastritis and hyperplastic polyps were seen in the same stomach.
The results of this study suggest that a greater amount of carcinogen, i.e., a higher total dose, is required for
the development of well differentiated adenocarcinoma than for inducing poorly differentiated adeno-
carcinoma and signet ring cell carcinoma.
Since the beginning of this century, many experi-
mental attempts have been made to produce a
reliable experimental model simultaing human
gastric cancer. Little success has been achieved
because of the difficulty in inducing gastric cancer
in small animals by oral administration of carcino-
genic agents.
Stewart et al. (1961) reported the development of
adenocarcinoma in the glandualr stomachs of rats
that had received N,N-2,7-fluorenylenebisacetamide
orally. However, this experimental method was
unsatisfactory, because adenocarcinoma occurred at
a low rate and it was not limited especially to the
stomach.
Sugimura & Fujimura (1967) found that N-
methyl-N'-nitro-N-nitrosoguanidine (MNNG) could
induce gastric cancer in the glandular stomachs of
rats at a relatively high rate, when the drug was
given in drinking water.
Kurihara et al. (1974) utilized N-ethyl-N'-nitro-
N-nitrosoguanidine (ENNG), a chemical derivative
of MNNG, and were also able to obtain a high
incidence of cancer development specifically in the
stomach of rats and dogs. These animal models are
very similar to human gastric cancer both macro-
scopically and microscopically.
For several years, we have studied the develop-
ment of gastric cancer using the experimental model
based on ENNG.
In this paper, the relationship of the duration of
ENNG administration to the histopathological
differentiation of the gastric carcinoma is demon-
strated.
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Materials and methods
Animals and carcinogen
Twenty-three adult Beagle dogs (13 males, 10
females) weighing 6.0-12.0kg were used. They were
fed CLEA #4 chow for dogs (CLEA Japan Inc.,
Tokyo). ENNG (Aldrich Chemical Co., Milwaukee,
USA) was orally administered according to the
method described below. A stock solution of
ENNG (1.5mgml -1 with 5% Tween 60) was
prepared once a week, and diluted 10-fold. ENNG
solution (150 ugml-1) and 20g of skim milk were
given as a substitute for drinking water twice every
day except on Sunday after each feeding with dog
food. After completion ofthe ENNG administration
schedule, the animals were allowed to continue
with dog food for varying periods. The dogs were
divided into three groups according to the dura-
tion of ENNG administration. In group 1, ENNG
solution was given to 10 dogs for 3 months, and
the total dose of ENNG was 5.85g per dog. In
group 2, 7 dogs were administered ENNG solution
for 6 months, and the total dose of ENNG was
11.70g. In group 3, 6 dogs were funrished with the
carcinogen for 9 months. The total dose was
17.55g.
Endoscopic examination and biopsy
The animals were routinely examined every 2 or 3
months using a gastrofiberscope (Olympus CIF-K2)
under i.v. anesthesia comprising thiopental sodium
at a dose of 25mgkg-1 body weight. More than 3
specimens were biopsied from the antrum, angulus
and fundus of the stomach.
I The Macmillan Press Ltd., 1985772 M. SUNAGAWA et al.
Gastrectomy or necropsy
After the administration schedule was completed,
the dogs were either surgically gastrectomized or
killed at varying follow-up periods. The stomachs
were opened at the greater curvature and subjected
to careful macroscopic examination, and then fixed
in 10% formalin for histologic examination. The
fixed stomachs were cut into 5mm-wide longitudinal
strips and were embedded in paraffin. Five Mm
thick sections were made and stained with H & E.
Alcian blue (pH 2.5)-periodic acid Schiff (PAS)
stains were used when necessary. Adenocarcinomas
were classified according to the WHO classification
(Oota & Sobin, 1977).
Results
Tumour incidence
ENNG-induced gastric carcinomas were observed
in 5 of 10 (50%) group 1 dogs (Table I). By the
endoscopic examination, hyperaemic lesions were
observed on the antral mucosa during the
administration of ENNG, but those disappeared
soon after the completion of administration. No
ulcerative lesion was observed at this time.
Although in each stomach of four dogs (nos. 4, 5, 6
and 8), followed up from 7.5 to 17.0 months, no
abnormalities were noticed on macroscopic
examination, confirmative histological examination
of the entire stomach showed multiple foci of signet
ring cell carcinomas (Figure 1). In animal no. 10,
followed up over 4 years, the antral stomach was
occupied by a single lesion of advanced ulcerated
infiltrative carcinoma of Borrmann's type III.
Histological examination showed that poorly
differentiated adenocarcinoma was predominant in
comparison with signet ring cell carcinoma and had
deeply invaded beyond the serosal lining with
positive regional lymph node metastatis (Figure 2).
Table II shows 100% incidence of
adenocarcinoma in all the seven stomachs of group
2 dogs. In four dogs (nos. 11, 12, 13 and 14), killed
or gastrectomized at 6.0 to 10.0 months, micro-
scopic examination showed that all the minute foci
of adenocarcinomas were limited to the tunica
mucosa of the antrum. Another three dogs (nos. 15,
16 and 17), examined at 13, 17 and 24 months
respectively, had polypoid and ulcerated lesions
synchronously in the gastric antrum (Figure 3).
About a half of these lesions had been hyperaemic
lesions at the early stage. Three of these tumours
were typical advanced carcinomas. One of them
was Borrmann's type II, and two of them were
Borrmann's type III. They apparently needed less
time for growth from early to advanced gastric
carcinoma as indicated by periodic endoscopic
examinations.
As shown in Table III, numerous adeno-
carcinomas were detected in all 6 Beagle dogs of
group 3. About two-thirds of these lesions had been
hyperaemic lesions at the early stage. The growth
rate of the carcinomas was endoscopically proved
to be similar to that of group 2. In 3 of 6 dogs
(nos. 18, 19 and 20), early cancerous lesions were
observed, and in the other 3 dogs (nos. 21, 22 and
23), advanced carcinomas were found in the antrum
of the stomach. One of advanced gastric cancers
was Borrmann's type II, and the other two were
Borrmann's type III (Figure 4).
Tumour location andhistological type
In group 1, all the early gastric cancers, defined as
intramucosal carcinoma or submucosal carcinoma,
were observed in the antral mucosa adjacent to the
intermediate zone of the stomach. The histological
type was typical signet ring cell carcinoma (Figure
5). The tumour cells were stained with Alcian blue-
periodic acid-Schiff.
In groups 2 and 3, early gastric cancers lay
Table 1 Incidences ofgastric carcinomas in group 1
Experimental
Case no. Sex period (months) Grossfindings No. oflesions
1 M 4.0 0
2 F 4.0 0
3 M 5.0 0
4 F 7.5 early (flat) 1
5 M 7.5 early (flat) 6
6 M 9.5 early (flat) 2
7 F 16.0 0
8 M 17.0 early (flat) 2
9 F 28.0 - 0
10 M 53.0 advanced I
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Figure 2 (a) Advanced gastric cancer showing irregular border of the ulcerative lesion and shaggy base in the
antrum. (b) Poorly differentiated tumour cells in the tunica serosa. H & E ( x 130).
scattered widely in the antrum of the stomach.
Histologically these cancers were well differentiated
adenocarcinomas, poorly differentiated adeno-
carcinomas and/or signet ring cell carcinomas. The
former lesions were often seen in the pylorus of the
stomachs, and many of the latter lesions were
located in the area similar to that of group 1
(Figure 6 and 7).
Table IV shows that all the cancerous foci of
group 1 were either signet ring cell carcinoma or
poorly differentiated adenocarcinoma. In cases
where two or more lesions coexisted in the same
stomach of group 2 or 3 animals, one of them was
well differentiated adenocarcinoma, and the other
was poorly differentiated and/or signet ring cell
carcinoma. In 12 of 13 dogs of groups 2 and 3, well
differnetiated adenocarcinomas were recognized in
every stomach. Atrophic hyperplastic gastritis and
hyperplastic polyps were often seen in the antrum
of the same stomachs.
Discussion
The correlation between the dosage of carcinogen
and tumour incidence has been an essentialENNG AND EXPERIMENTAL GASTRIC CANCER 775
Table II Incidences ofgastric carcinomas in group 2
Experimental
Case no. Sex period (months) Grossfindings No. oflesions
11 F 6.0 early (flat) 2
12 M 7.5 early (flat) 1
13 M 9.5 early (flat) 2
14 F 10.0 early (flat) 3
15 M 13.0 early 3
(elevated & depressed)
advanced (Borrmann 2)
16 M 17.0 early 3
(polypoid & depressed)
advanced (Borrmann 3)
17 F 24.0 early (polypoid) 3
advanced (Borrmann 3)
Figure 3 (a) Three cancerous lesions in the same stomach. (1) An advanced gastric cancer; (2) A depressed
early gastric cancer; (3) A protruded early gastric cancer. (b) Poorly differentiated tumour cells in the border
of the ulcerative lesion. H & E ( x 130). (c) Well differentiated adenocarcinoma at the top of hyperplastic
polyp. H & E(x21).
Table III Incidences of gastric carcinomas in group 3
Experimental
Case no. Sex period (months) Grossfindings No. oflesions
18 M 10.0 early 2
(flat & elevated)
19 M 13.0 early 2
(elevated & depressed)
20 M 17.0 early 8
(flat, polypoid,
depressed & combined
(elevated & depressed))
21 F 19.0 advanced (Borrmann 3) 1
22 F 21.0 early 10
(flat & depressed)
advanced (Borrmann 2)
23 F 23.0 early (elevated) 3
advanced (Borrmann 3)
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Figure 4 (a) An advanced ulcerated infiltrative cancer in the distal protion of the stomach. (b) Well
differentiated adenocarcinoma and poorly differentiated adenocarcinoma in the same cancerous lesion. H & E
(x 52).
Figure 5 Locations and histological types of all early gastric cancers detected in group I. (0) Signet ring cell
carcinoma.ENNG AND EXPERIMENTAL GASTRIC CANCER 777
Figure 6 Locations and histological types of all early gastric cancers detected in group II. (0) Well
differentiated adenocarcinoma; (0) poorly differentiated adenocarcinoma or signet ring cell carcinoma.
Figure 7 Locations and histological types of all early gastric cancers detected in the group III. (0) Well
differentiated adenocarcinoma; (0) poorly differentiated adenocarcinoma or signet ring cell carcinoma.
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Table IV Histological classification ofgastric carcinomaa
No. ofwell No. ofpoorly No. of
Experimental differentiated differentiated signet ring Total no. of
group adenocarcinoma adenocarcinoma cell carcinoma lesions
1 0 1 11 12
2 7 9 1 17
3 13 11 2 26
aAccording to WHO classification, Oota et al. (1977).
problem in the experimental production of any kind
of carcinoma.
In the study of experimental gastric cancer when
MNNG or ENNG was used, the adequate concen-
tration, duration and total dose of carcinogen
were discussed in relation to induction of adeno-
carcinoma with high incidence. Saito et al. (1978)
used MNNG at concentrations of 50 and
83 gml-P for 35 to 63 weeks to produce canine
gastric cancer, and Kurihara et al. (1974) reported
the development of carcinoma by oral administra-
tion of 250ml of a 150jgmlF- solution of ENNG
twice a day for 8 months. However, according to
their results, well differentiated carcinoma, poorly
differentiated carcinoma and signet ring cell carci-
noma developed together, the first especially with a
high incidence. Therefore, canine gastric cancer
induced by their method was criticized as an in-
appropriate model of human gastric cancer.
In our experiments, we used a single carcinogen
at regular concentrations to study the effect of
duration of administration on the development of
carcinomas.
During short term administration, the total dose
of ENNG was 5.85g in group 1, and this induced
signet ring cell cancer or poorly differentiated
adenocarcinoma.
By contrast, in group 2 (total dose, 11.70g) and
group 3 (total dose, 17.55g), well differentiated
adenocarcinomas were found in almost all
specimens along with poorly differentiated adeno-
carcinomas. These findings indicate that the longer
the duration of ENNG administration (i.e. the
greater the total dose of ENNG), the greater the
likelihood that well differentiated carcinomas will
be induced.
In the study of colonic tumour in Wistar rats
induced by 1,2-dimethylhydrazine, Shirai et al.
(1983) found that the number of tubular adeno-
carcinomas was dose-related. Fujita et al. (1981)
reported that poorly differentiated adenocarcinomas
along with signet ring cell carcinomas were induced
in dogs by giving a low concentration of ENNG
(50jugml -1) for 30 to 52 weeks. This evidence
agrees with our data.
Thus we may conclude that a larger dose of
carcinogen is required for the development of well
differentiated types of carcinoma than for the
development of poorly differentiated or signet ring
cell carcinomas.
In a previous report (Sunagawa, 1981), we
described how signet ring cell carcinomas induced
by ENNG develop from the generative zone of the
gastric epithelial gland and grow upwards and
laterally. After forming a double-layer structure, the
atypical cells infiltrate into the lamina propria
through the basement membrane of the epithelial
gland.
As shown in Figure 1 (b), mucus was retained in
the cytoplasm of malignant cells in the lesion at this
stage. The surface of the lesion was covered with a
normal layer of fovela epithelium, and the pyloric
gland (or pseudo-pyloric gland) under the lesion
appeared almost normal without any atrophy or
hyperplasia. There was substantial no cellular
infiltration into the stroma around the lesion. From
the above findings, this lesion was morphologically
judged to be signet ring cell carcinoma or poorly
differentiated caricinoma. As this lesion was so
minute, it could not be established whether it was a
potential infiltrative and metastatic advanced
carcinoma or not. However, as seen in dog no. 10
of group 1, a IIc carcinoma found endoscopically
28 months after the end of 3 months administration
of ENNG grew to advanced carcinoma of
Borrmann's type III in 35 months, and necropsy at
50 months revealed that it had grown to large
advanced carcinoma accompanied by lymph node
metastasis. Therefore, it can be presumed that some
of the minute carcinomas would have become
advanced carcinomas. We suspect that the pattern
of development of well differentiated adeno-
carcinomas differs from that of poorly differen-
tiated or signet ring cell carcinomas.
In the stomachs of Beagle dogs in groups 2 and
3, atrophic hyperplastic gastritis and hyperplastic
polyps were seen in the pyloric gland areas. In
many cases, well differentiated adenocarcinomas
were detected in the hyperplastic polyps, in the
deep side of the atrophic glands and/or theENNG AND EXPERIMENTAL GASTRIC CANCER 779
generative glands of epithelium. Around the lesions,
there was mild, moderate and severe epithelial
dysplasia. This finding suggests that a certain
number of hyperplastic polyps underwent malig-
nant transformation, and that atrophic or
generative changes of the epithelial glands are
necessary for the development of well differentiated
adenocarcinoma.
Intestinal metaplasia of gastric epithelium has
been considered to be a precancerous lesion of well
differentiated adenocarcinoma as a result of
investigations of human gastric cancer (Morson,
1955; Lauren, 1965; Nakamura et al. 1968). During
experimental studies, intestinal metaplasia was
induced by MNNG administration only in rats
(Matsukura et al., 1978), but the distribution of
these intestinal metaplasia is dissimilar from that in
humans. In our experiment, it was not proved that
intestinal metaplasia of the stomach is one of the
precancerous lesions for the development of well
differentiated adenocarcinomas.
Further experimental studies are required to
answer the vital question as to whether or not
gastric carcinoma really develops from intestinal
metaplasia epithelium in the stomach.
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